Ross Stores, Inc. vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Ross Stores, Inc. trades at $226 (market cap $72.05B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Ross Stores, Inc. is far larger — about 31.6× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Ross Stores, Inc. pays a 0.79% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| ROST | SLS | |
|---|---|---|
Market Cap | $72.05B | $2.28B |
Volume | 1,674,861 | 3,128,960 |
Sector | Consumer Cyclical | Health |
52-Week High | $255.23 | $15.46 |
52-Week Low | $147.71 | $1.39 |
Typical Hold Time | 48 Days | — |
Enterprise Value | $72.50B | $2.15B |
Dividend Yield | 0.79% | — |
Signals from Pluang's Aura AI — not financial advice
Ross Stores (ROST) trades at $225.20, up 0.44% today, showing strong fundamental performance with consistent earnings beats and robust profitability metrics including 42.63% ROE and 10.85% net margin. The stock faces technical headwinds with a bearish signal from moving averages, trading near support at $224. Recent news highlights store expansion initiatives and strong closeout supply benefits as the company captures value-conscious shoppers amid competitive retail pressures.
ROST presents a compelling investment case with analyst consensus pointing to 22% upside to the $274.14 price target, supported by strong earnings momentum and expanding margins. Key risks include retail competition, cost pressures, and macroeconomic sensitivity, but the company's value-focused strategy and operational discipline position it well for sustained growth.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →